SCHEMBL4354919

SCHEMBL4354919

Cc1c(Cl)cc(NCc2cccc(Oc3ccc(Cl)cc3)c2)c(O)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
FFAR1 O14842 7/20 0.41
PPARG P37231 3/20 0.41
PPARA Q07869 3/20 0.41
LMNA P02545 2/20 0.41
HDAC8 Q9BY41 1/20 0.41
MAPT P10636 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GNA15 P30679 1/20 0.38
PTGER3 P43115 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PPARD Q03181 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4357552 0.93 HDAC8 (0.47) ALDH1A1FFAR1HDAC8MAPTHTT
SCHEMBL4343612 0.92 ALDH1A1 (0.50) ALDH1A1FFAR1HDAC8MAPTHTT
SCHEMBL12846780 0.89 FAAH (0.39) ALDH1A1FFAR1PPARGPPARALMNA
SCHEMBL4351954 0.83 STK39 (0.45) ALDH1A1FFAR1PPARGPPARALMNA
SCHEMBL4342411 0.82 FFAR1 (0.45) ALDH1A1FFAR1PPARGPPARALMNA
SCHEMBL12846749 0.82 MEN1 (0.56) ALDH1A1FFAR1LMNAMAPTKDM4E
SCHEMBL4345563 0.80 BRD4 (0.49) PPARG
SCHEMBL4351839 0.79 HDAC8 (0.45) ALDH1A1LMNAHDAC8MAPTHTT
SCHEMBL4347926 0.78 FFAR1 (0.52) ALDH1A1FFAR1PPARGPPARALMNA
SCHEMBL4350844 0.78 HTT (0.55) ALDH1A1FFAR1LMNAHDAC8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US disclosed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US disclosed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 ALDH1A1 2565/4885FFAR1 736/4885PPARG 417/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 ALDH1A1 2767/4885FFAR1 780/4885PPARG 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.